Core Viewpoint - Impact Biomedical Inc. has received a new patent for a composition and method aimed at controlling infectious diseases, showcasing its commitment to innovative healthcare solutions [1][2][3]. Company Summary - The newly issued U.S. patent No. 12,357,584 B2 is titled "Composition and Method of Controlling Infectious Diseases with Functional Fragrances" and is part of the company's 3F™ technology platform [1][2]. - This patent expands the company's existing patent estate, which includes insect repellent and antimicrobial applications, indicating a strategic focus on addressing unmet healthcare needs [3]. - The CEO of Impact Biomedical emphasized the success of their business model in delivering proprietary technology aimed at improving human healthcare [8]. Product and Technology Summary - The patented compositions consist of plant-derived constituents and fragrances, which have demonstrated unique antimicrobial and antiviral properties [2][4]. - Potential applications of these compositions include their use as disinfectants and treatments for various infectious diseases, targeting pathogens such as E. coli, MRSA, influenza, rhinovirus, and M. tuberculosis [5][6]. - The global infectious disease market is projected to grow significantly, from $21.7 billion in 2024 to $34 billion in 2033, reflecting a compound annual growth rate (CAGR) of 5.77% [7].

Company Overview - SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on developing innovative medicines to treat and prevent infectious diseases, particularly orthopoxviruses [4] - The company aims to protect against severe infectious diseases through partnerships with governments and public health agencies [4] - SIGA's flagship product, TPOXX (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for smallpox treatment and authorized in Europe, the UK, and Japan for smallpox, mpox, cowpox, and vaccinia complications [4] Upcoming Events - Management will host a webcast and conference call on August 5, 2025, at 4:30 P.M. ET to provide a business update [1] - The call will feature CEO Diem Nguyen and CFO Daniel Luckshire [1] - A live webcast will be available on the company's website, and participants are encouraged to log in 5-10 minutes prior to the start time [2] Access and Replay Information - Participants can access the call by dialing specific numbers for domestic and international callers [2] - A replay of the call will be available for two weeks using designated numbers and Conference ID [3] - The archived webcast will also be accessible in the Investor Relations section of the company's website [3]